AbbVie to buy drug maker Cerevel for $8.7bn

AbbVie said on Wednesday it would buy Cerevel Therapeutics, a developer of drugs to treat neurological diseases, for about $8.7bn to offset proceeds from its arthritis drug Humira.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM